Terms: = Colorectal cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169
220 results:
1. Long non-coding RNA HOTAIR: from pan-cancer analysis to colorectal cancer-related uridine metabolism.
Chen X; Wang S; Jiang X; Zhang M; Ding Y
Aging (Albany NY); 2024 May; 16(9):7752-7773. PubMed ID: 38696320
[TBL] [Abstract] [Full Text] [Related]
2. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by ezh2 Inhibition in colorectal Carcinoma Cells.
Jacksi M; Schad E; Tantos A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
[TBL] [Abstract] [Full Text] [Related]
3. Telomere dysfunction alters intestinal stem cell dynamics to promote cancer.
LaBella KA; Hsu WH; Li J; Qi Y; Liu Y; Liu J; Wu CC; Liu Y; Song Z; Lin Y; Blecher JM; Jiang S; Shang X; Han J; Spring DJ; Zhang J; Xia Y; DePinho RA
Dev Cell; 2024 Jun; 59(11):1475-1486.e5. PubMed ID: 38574731
[TBL] [Abstract] [Full Text] [Related]
4. Select ezh2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
[TBL] [Abstract] [Full Text] [Related]
5. ezh2 Inhibition Enhances PD-L1 Protein Stability Through USP22-Mediated Deubiquitination in colorectal cancer.
Huang J; Yin Q; Wang Y; Zhou X; Guo Y; Tang Y; Cheng R; Yu X; Zhang J; Huang C; Huang Z; Zhang J; Guo Z; Huo X; Sun Y; Li Y; Wang H; Yang J; Xue L
Adv Sci (Weinh); 2024 Jun; 11(23):e2308045. PubMed ID: 38520088
[TBL] [Abstract] [Full Text] [Related]
6. Knocking down of lncRNA SBF2-AS1 inhibits proliferation, invasion and induces apoptosis of colorectal cancer through regulating PTEN.
Cai Y; Yan H; Wang F; Xie L
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):201-205. PubMed ID: 38279439
[TBL] [Abstract] [Full Text] [Related]
7. ezh2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract] [Full Text] [Related]
8. Down-regulation of ezh2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway.
Liang G; Han L; Qu M; Xue J; Xu D; Wu X; Lu Y
Aging (Albany NY); 2023 Dec; 15(23):13655-13668. PubMed ID: 38048186
[TBL] [Abstract] [Full Text] [Related]
9. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.
Firouzjaei AA; Aghaee-Bakhtiari SH; Tafti A; Sharifi K; Abadi MHJN; Rezaei S; Mohammadi-Yeganeh S
Cell Biochem Funct; 2023 Dec; 41(8):1488-1502. PubMed ID: 38014635
[TBL] [Abstract] [Full Text] [Related]
10. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
Zhang J; Li C; Sun L; Sun D; Zhao T
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
[TBL] [Abstract] [Full Text] [Related]
11. TRIM29 promotes the progression of colorectal cancer by suppressing ezh2 degradation.
Chen Y; Ma J; Zhang M
Exp Biol Med (Maywood); 2023 Sep; 248(18):1527-1536. PubMed ID: 37837384
[TBL] [Abstract] [Full Text] [Related]
12. Phosphorylation of ezh2 differs HER2-positive breast cancer invasiveness in a site-specific manner.
Yu F; Li L; Zhang M; Sun S
BMC Cancer; 2023 Oct; 23(1):948. PubMed ID: 37803297
[TBL] [Abstract] [Full Text] [Related]
13. Network pharmacology-based anti-colorectal cancer activity of piperlonguminine in the ethanolic root extract of Piper longum L.
Singh I; Das R; Kumar A
Med Oncol; 2023 Oct; 40(11):320. PubMed ID: 37796360
[TBL] [Abstract] [Full Text] [Related]
14. MHC Class II is Induced by IFNγ and Follows Three Distinct Patterns of Expression in colorectal cancer Organoids.
Pickles OJ; Wanigasooriya K; Ptasinska A; Patel AJ; Robbins HL; Bryer C; Whalley CM; Tee L; Lal N; Pinna CMA; Elzefzafy N; Taniere P; Beggs AD; Middleton GM
Cancer Res Commun; 2023 Aug; 3(8):1501-1513. PubMed ID: 37565053
[TBL] [Abstract] [Full Text] [Related]
15. ezh2 Expression and Survival for ER+/tamoxifen Treated Breast cancer Patients with rs2302427 C>G: A Novel Prognostic and Risk Predictive Biomarker.
Gautam N; Kaur S; Kashyap S
Arch Med Res; 2023 Jul; 54(5):102852. PubMed ID: 37438214
[TBL] [Abstract] [Full Text] [Related]
16. Combined inhibition of ezh2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells.
Long Y; Wang Y; Qu M; Zhang D; Zhang X; Zhang J
Cancer Lett; 2023 Jul; 566():216226. PubMed ID: 37230222
[TBL] [Abstract] [Full Text] [Related]
17. ezh2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Chen J; Hong JH; Huang Y; Liu S; Yin J; Deng P; Sun Y; Yu Z; Zeng X; Xiao R; Chan JY; Guan P; Wang Y; Wang P; Liu L; Wen S; Yu Q; Ong CK; Teh BT; Xiong Y; Tan J
Mol Cancer; 2023 May; 22(1):85. PubMed ID: 37210576
[TBL] [Abstract] [Full Text] [Related]
18. Phosphorylation and stabilization of ezh2 by DCAF1/VprBP trigger aberrant gene silencing in colon cancer.
Ghate NB; Kim S; Shin Y; Kim J; Doche M; Valena S; Situ A; Kim S; Rhie SK; Lenz HJ; Ulmer TS; Mumenthaler SM; An W
Nat Commun; 2023 Apr; 14(1):2140. PubMed ID: 37069142
[TBL] [Abstract] [Full Text] [Related]
19. BZW2 Inhibition Reduces colorectal cancer Growth and Metastasis.
Agarwal S; Afaq F; Bajpai P; Behring M; Kim HG; Varambally A; Chandrashekar DS; Peter S; Diffalha SA; Khushman M; Seeber A; Varambally S; Manne U
Mol Cancer Res; 2023 Jul; 21(7):698-712. PubMed ID: 37067340
[TBL] [Abstract] [Full Text] [Related]
20. Combinatorial Network of Transcriptional and miRNA Regulation in colorectal cancer.
Kumar R; Mahmoud MM; Tashkandi HM; Haque S; Harakeh S; Ponnusamy K; Haider S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982429
[TBL] [Abstract] [Full Text] [Related]
[Next]
